Depression, Violence and Socioeconomic Outcomes Among Refugees in East Africa: Evidence from a Multicountry Representative Survey
Overview
Affiliations
Background: Existing research on refugee mental health is heavily skewed towards refugees in high-income countries, even though most refugees (83%) are hosted in low-income and middle-income countries. This problem is further compounded by the unrepresentativeness of samples, small sample sizes and low response rates.
Objective: To present representative findings on the prevalence and correlates of depression among different refugee subgroups in East Africa.
Methods: We conducted a multicountry representative survey of refugee and host populations in urban and camp contexts in Kenya, Uganda and Ethiopia (n=15 915). We compared the prevalence of depression between refugee and host populations and relied on regression analysis to explore the association between violence, depression and socioeconomic outcomes.
Findings: We found a high prevalence of elevated depressive symptoms (31%, 95% CI 28% to 35%) and functional impairment (62%, 95% CI 58% to 66%) among the refugee population, which was significantly higher than that found in the host population (10% for depressive symptoms, 95% CI 8% to 13% and 25% for functional impairment, 95% CI 22% to 28%) (p<0·001). Further, we observed a dose-response relationship between exposure to violence and mental illness. Lastly, high depressive symptoms and functional impairment were associated with worse socioeconomic outcomes.
Conclusion: Our results highlight that refugees in East-Africa-particularly those exposed to violence and extended exile periods-are disproportionately affected by depression, which may also hinder their socioeconomic integration.
Clinical Implications: Given the high prevalence of depression among refugees in East Africa, our results underline the need for scalable interventions that can promote refugees' well-being.
Shibeshi A, Moloro A, Kase B, Wubshet B, Seid A PLoS One. 2025; 20(2):e0318904.
PMID: 39932901 PMC: 11813089. DOI: 10.1371/journal.pone.0318904.
Ewunie T, Hayen A, Dawson A Health Promot Int. 2025; 40(1.
PMID: 39820457 PMC: 11739720. DOI: 10.1093/heapro/daae199.
Shibeshi A, Kase B, Moloro A, Mehari M, Seid A BMC Psychiatry. 2024; 24(1):924.
PMID: 39695510 PMC: 11657704. DOI: 10.1186/s12888-024-06371-1.
Osman W, Ncube F, Shaaban K, Dafallah A PLoS One. 2024; 19(6):e0305495.
PMID: 38913631 PMC: 11195976. DOI: 10.1371/journal.pone.0305495.